Literature DB >> 20395415

Redox regulation of T-cell turnover by the p13 protein of human T-cell leukemia virus type 1: distinct effects in primary versus transformed cells.

Micol Silic-Benussi1, Ilaria Cavallari, Nicola Vajente, Silvia Vidali, Luigi Chieco-Bianchi, Fabio Di Lisa, Daniela Saggioro, Donna M D'Agostino, Vincenzo Ciminale.   

Abstract

The present study investigated the function of p13, a mitochondrial protein of human T-cell leukemia virus type 1 (HTLV-1). Although necessary for viral propagation in vivo, the mechanism of function of p13 is incompletely understood. Drawing from studies in isolated mitochondria, we analyzed the effects of p13 on mitochondrial reactive oxygen species (ROS) in transformed and primary T cells. In transformed cells (Jurkat, HeLa), p13 did not affect ROS unless the cells were subjected to glucose deprivation, which led to a p13-dependent increase in ROS and cell death. Using RNA interference we confirmed that expression of p13 also influences glucose starvation-induced cell death in the context of HTLV-1-infected cells. ROS measurements showed an increasing gradient from resting to mitogen-activated primary T cells to transformed T cells (Jurkat). Expression of p13 in primary T cells resulted in their activation, an effect that was abrogated by ROS scavengers. These findings suggest that p13 may have a distinct impact on cell turnover depending on the inherent ROS levels; in the context of the HTLV-1 propagation strategy, p13 could increase the pool of "normal" infected cells while culling cells acquiring a transformed phenotype, thus favoring lifelong persistence of the virus in the host.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395415     DOI: 10.1182/blood-2009-07-235861

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.

Authors:  Vibeke Andresen; Cynthia A Pise-Masison; Uma Sinha-Datta; Marcia Bellon; Valerio Valeri; Robyn Washington Parks; Valentina Cecchinato; Risaku Fukumoto; Christophe Nicot; Genoveffa Franchini
Journal:  Blood       Date:  2011-06-15       Impact factor: 22.113

2.  High-yield production in E. coli and characterization of full-length functional p13II protein from human T-cell leukemia virus type 1.

Authors:  Elka R Georgieva; Peter P Borbat; Christina Fanouraki; Jack H Freed
Journal:  Protein Expr Purif       Date:  2020-04-30       Impact factor: 1.650

3.  Functional implications of mitochondrial reactive oxygen species generated by oncogenic viruses.

Authors:  Young Bong Choi; Edward William Harhaj
Journal:  Front Biol (Beijing)       Date:  2014-12

4.  Superoxide-Generating Nox5α Is Functionally Required for the Human T-Cell Leukemia Virus Type 1-Induced Cell Transformation Phenotype.

Authors:  Tomonari Shigemura; Masaaki Shiohara; Masayoshi Kato; Shuichi Furuta; Kazuko Kaneda; Kazuhiro Morishita; Hiroo Hasegawa; Masahiro Fujii; Agnes Gorlach; Kenichi Koike; Tohru Kamata
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

Review 5.  Human T-cell lymphotropic virus type 1 and its oncogenesis.

Authors:  Lan-Lan Zhang; Jing-Yun Wei; Long Wang; Shi-le Huang; Ji-Long Chen
Journal:  Acta Pharmacol Sin       Date:  2017-04-10       Impact factor: 6.150

6.  Glutathione reductase system changes in HTLV-1 infected patients.

Authors:  Sajad Ehtiati; Masoud Youssefi; Houshang Rafatpanah; Baratali Mashkani; Majid Khadem-Rezaiyan; Farnaz Zahedi Avval
Journal:  Virusdisease       Date:  2022-03-22

Review 7.  Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.

Authors:  Dustin Edwards; Claudio Fenizia; Heather Gold; Maria Fernanda de Castro-Amarante; Cody Buchmann; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  Viruses       Date:  2011-06-17       Impact factor: 5.048

Review 8.  Converging strategies in expression of human complex retroviruses.

Authors:  Ilaria Cavallari; Francesca Rende; Donna M D'Agostino; Vincenzo Ciminale
Journal:  Viruses       Date:  2011-08-11       Impact factor: 5.048

9.  Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.

Authors:  Francesca Rende; Ilaria Cavallari; Maria Grazia Romanelli; Erica Diani; Umberto Bertazzoni; Vincenzo Ciminale
Journal:  Leuk Res Treatment       Date:  2011-12-29

10.  Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  Front Microbiol       Date:  2012-12-11       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.